|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2500 MYR | +21.95% |
|
-.--% | - |
| 04-29 | Supergenics Berhad Auditor Raises 'Going Concern' Doubt | CI |
| 02-27 | Supergenics Berhad Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 7.14M | - | - | - | - | - |
| 50.35B | |||||
| 39.32B | - | - | - | - | - |
| 34.69B | |||||
| 34.08B | |||||
| 26.63B |
- Stock Market
- Stocks
- 03033 Stock
- Charts Supergenics
- Sector Chart
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
